Prelude Therapeutics IncorporatedPRLDNASDAQ
Loading
Year-over-year book value per share growth
Latest
41.81%
↑ 64% vs avg
Percentile
P93
Near historical high
Streak
2 qtr
Consecutive growthAccelerating
Average
25.45%
Historical baseline
| Period | Value |
|---|---|
| Q4 2025 | 41.81% |
| Q3 2025 | -22.96% |
| Q2 2025 | -26.51% |
| Q1 2025 | -21.61% |
| Q4 2024 | -16.01% |
| Q3 2024 | -14.29% |
| Q2 2024 | -13.53% |
| Q1 2024 | -18.33% |
| Q4 2023 | -3.28% |
| Q3 2023 | -24.41% |
| Q2 2023 | 26.89% |
| Q1 2023 | -10.00% |
| Q4 2022 | -10.95% |
| Q3 2022 | -10.06% |
| Q2 2022 | -8.42% |
| Q1 2022 | -9.86% |
| Q4 2021 | -8.14% |
| Q3 2021 | -7.46% |
| Q2 2021 | -8.13% |
| Q1 2021 | 41.72% |
| Q4 2020 | -7.06% |
| Q3 2020 | 743.27% |
| Q2 2020 | 0.00% |
| Q1 2020 | 100.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |